Brain Cancer section

Brain Cancer News and Features

Clinician Interaction Scored High, Some Discussion Topics Did Not in Patient Assessment of Quality of Care

Clinician Interaction Scored High, Some Discussion Topics Did Not in Patient Assessment of Quality of Care

In a survey of patients' perceptions, doctor/nurse interactions were rated high; however, some specific topics for discussion were not rated as high.

CNS Tumors in Childhood: Predicting Successful Independence in Adult Life

CNS Tumors in Childhood: Predicting Successful Independence in Adult Life

Researchers at St Jude Children's Research Hospital sought to determine what indicators in survivors of CNS tumors can predict the survivor's ability to live independently as an adult.

Durable Response Achieved With Nivolumab in Untreated Melanoma Brain Metastases

Durable Response Achieved With Nivolumab in Untreated Melanoma Brain Metastases

In this phase 2 study, researchers randomly assigned 79 patients with immunotherapy-naive melanoma with brain metastases to receive either nivolumab plus ipilimumab or nivolumab alone.

Prognostic Significance of Epidermal Growth Factor Receptor Expression in Glioma Patients

Prognostic Significance of Epidermal Growth Factor Receptor Expression in Glioma Patients

[OncoTargets and Therapy] A meta-analysis was conducted to evaluate the effect of abnormal EGFR expression on overall survival (OS) in patients with glioma.

Tumor-treating Fields Useful to Improve Glioblastoma Outcomes

Tumor-treating Fields Useful to Improve Glioblastoma Outcomes

Adverse event rates were similar in both trial groups, though patients treated with TTFields were much more likely to have mild to moderate skin toxicity.

Brain Cancer Clinical Trials

Clinician Interaction Scored High, Some Discussion Topics Did Not in Patient Assessment of Quality of Care

In a survey of patients' perceptions, doctor/nurse interactions were rated high; however, some specific topics for discussion were not rated as high.

ASCO, SITC Release Recommendations for Clinical Trial Reporting of Immunotherapy Adverse Events

As immunotherapies gain a stronger foothold as a treatment option for cancer, ASCO and SITC convened a panel to develop recommendations to ensure consistent and efficient clinical trial reporting in immuno-oncology.

Progression free survival poorly correlates with health-related quality of life in cancer trials

1. Progression free survival demonstrates poor-correlation with measures of health related quality of life (HRQoL) in oncology trials. 2. Current study demonstrate poor follow-up and reporting of HRQoL measures, likely introducing bias into published results. Evidence Rating Level:3 (Average) Study Rundown: Current stated goals for the American Society of Clinical Oncology include the focus on []

Delphi Panel Presents Recommendations for Expanding Role of Patients in Research

A Delphi panel developed recommendations for integrating patients, as well as caregivers and advocate, a greater role in medical research while maintaining scientific integrity of studies.

CNS Tumors in Childhood: Predicting Successful Independence in Adult Life

Researchers at St Jude Children's Research Hospital sought to determine what indicators in survivors of CNS tumors can predict the survivor's ability to live independently as an adult.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs